SCHEMBL28067006

SCHEMBL28067006

CCCCCCCCC(C(=O)O)C(C)Cl

nearest known ligand 0.69

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.53
FFAR1 O14842 2/20 0.53
ACE2 Q9BYF1 1/20 0.53
MAPT P10636 1/20 0.52
LCK P06239 1/20 0.52
PPARD Q03181 1/20 0.52
ZDHHC20 Q5W0Z9 1/20 0.52
ZDHHC2 Q9UIJ5 1/20 0.52
ALDH1A1 P00352 1/20 0.45
GRIK1 P39086 1/20 0.44
GRIK2 Q13002 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
CA1 P00915 2/20 0.44
FAAH O00519 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9446898 1.00 GPR84 (0.53) GPR84FFAR1ACE2MAPTLCK
SCHEMBL10564207 1.00 GPR84 (0.53) GPR84FFAR1ACE2MAPTLCK
SCHEMBL28055051 0.98 GPR84 (0.50) GPR84FFAR1ACE2MAPTLCK
SCHEMBL11367204 0.92 CA2 (0.48) GPR84FFAR1ACE2MAPTLCK
SCHEMBL866880 0.86 GPR84 (0.55) GPR84FFAR1ACE2MAPTLCK
SCHEMBL10581578 0.86 GPR84 (0.55) GPR84FFAR1ACE2MAPTLCK
SCHEMBL9066915 0.85 GPR84 (0.64) GPR84FFAR1ACE2MAPTLCK
SCHEMBL337767 0.85 GPR84 (0.64) GPR84FFAR1ACE2MAPTLCK
SCHEMBL337012 0.85 GPR84 (0.64) GPR84FFAR1ACE2MAPTLCK
SCHEMBL5547897 0.85 GPR84 (0.64) GPR84FFAR1ACE2MAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103910738-B A kind of Bisbenzylisoquinolincompounds quaternary ammonium salt and preparation method thereof and the application in preparing antitumor drug 山东师范大学 2016-07-06 CN claimed
CN-115677718-A Methylmethylamine derivative preparation, pharmaceutical composition and application thereof 武汉思瓴生物科技有限公司 2023-02-03 CN disclosed